Lung cancer Flashcards

1
Q

Lung cancer symptoms

A

persistent new cough or change in character of pre-existing cough
persistent LRTIs
chest/shoulder pain
dyspnoea
haemoptysis
lethargy, weight loss, anorexia (constitutional symptoms)
hoarseness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Lung cancer signs

A

often none
clubbing
signs of lung collapse, consolidation, pleural effusion
localised persistent wheeze (monophonic)
stridor
supraclavicular lymphadenopathy
hoarseness
SVC obstruction
Horner’s syndrome
features of paraneoplastic syndromes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

SVC obstruction symptoms/signs

A

dyspnoea
orthopnoea
facial plethora
dilated/engorged veins
raised JVP
arm/face swelling

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What causes Horner’s syndrome?

A

compression of sympathetic chain at roughly the level of C1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Features of Horner’s syndrome

A

miosis (constricted pupil)
ptosis (upper eyelid drooping)
anhidrosis (no sweat produced on one side of face/forehead)
enophthalmos (sunken in eye)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are 2 lung cancer medical emergencies?

A

SVC obstruction
spinal cord compression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What investigations should be done if lung cancer is suspected?

A

CXR
CT staging (contrast) +/- biopsy
Bronchoscopy
Pulmonary function tests
6-minute-walk test
PET-CT scan
Bone scan
Cardiac investigations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is WHO performance status 0?

A

fully active and able to carry out pre-disease activities without restriction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is WHO performance status 1?

A

restricted in strenuous activity but ambulatory and able to carry out light work

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is WHO performance status 2?

A

ambulatory and self-caring, but unable to do light work
up and about more than 50% of the time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is WHO performance status 3?

A

limited self care
in bed more than 50 % of the time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is WHO performance status 4?

A

unable to self care
confined to bed or chair

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Non-small cell lung cancer subtypes

A

squamous cell carcinoma
adenocarcinoma
large cell carcinoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the 4 mesothelioma subtypes and which is the most common?

A

epithelioid (most common)
biphasic
sarcomatoid
desmoplastic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Where in the lung are small cell lung cancers normally located?

A

central

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Where in the lung are adenocarcinomas normally located?

A

peripheral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Where in the lung are squamous cell carcinomas normally located?

A

central airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where in the lung are large cell carcinomas normally located?

A

peripheral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What factors are considered when staging a lung cancer?

A

location of primary tumour
tumour size and extent
lymph node involvement
presence of distant metastases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Why is ist important to stage lung cancer?

A

common language for communicating the severity of a person’s cancer
prognostic information
determines treatment options

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What do TNM stand for in lung cancer staging?

A

T = tumour size
N = extent of spread to lymph nodes
M = presence of metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What invasive options are available for staging of a lung cancer?

A

EBUS-TBNA (endobronchial ultrasound-guided transbronchial needle aspiration - central nodules

thoracoscopy - small peripheral nodules

mediastinoscopy - mediastinal nodes or masses

23
Q

What imaging methods can be used to help stage a cancer?

A

CT
PET-CT

24
Q

What is the aim of biopsying the primary lesion?

A

Histological diagnosis

25
Q

Who is in the MDT for lung cancer?

A

respiratory physicians
thoracic surgeons
oncologists
radiologists
histopathologists
lung cancer specialist nurses
palliative care team

26
Q

Lung cancer management options (general)

A

surgery
chemotherapy
radiotherapy
palliation

27
Q

When is surgical management indicated for lung cancer?

A

stage 1 and 2 disease (and some stage 3 disease)

28
Q

Define resectability

A

ability to completely excise the tumour at surgery

29
Q

Define operability

A

risk of mortality/morbidity from surgery

30
Q

What are the 3 main factors considered when assessing operability in lung cancer

A

risk of post-operative cardiac event
risk of peri-operative death
risk of post-operative dyspnoea

31
Q

What are the 4 types of resection that can be done to remove lung cancers surgically?

A

wedge resection
segmental resection
lobectomy (most common)
pneumonectomy

32
Q

What does VATS stand for?

A

video-assisted thoracoscopic surgery

33
Q

Complications of surgery to remove lung cancer

A

displacement of heart towards operated side
bronchial stump insufficiency
pneumothorax (potentially tension pneumothorax)
postoperative haemorrhage (hemothorax)
chylothorax (damage to thoracic duct)
atelectasis
pneumonia

34
Q

Acute side effects of radiotherapy

A

oesophagitis
pneumonitis
nausea/vomiting
bone marrow suppression

35
Q

Longer term side effects of radiotherapy

A

pneumonitis and pulmonary fibrosis
rib fractures
cardiac fibrosis and dysfunction
hypothyroidism

36
Q

What cell functions can chemotherapy target?

A

DNA replication/repair
cytoskeleton
nucleotide synthesis
hormones
specific receptors (eg. herceptin)

37
Q

Is chemotherapy curative in lung cancer?

A

no

38
Q

Lung cancer risk factors

A

smoking (tobacco + cannabis)
passive smoking
occupation exposure (asbestos, silica, coal)
HIV
organ transplantation
radiation exposure

39
Q

Squamous cell carcinoma important features

A

usually obstructive lesions of bronchus
can cavitate
local spread common, often late metastasis
PTHrp production leading to hypercalcaemia
associated with clubbing and HPOA

40
Q

What is HPOA?

A

hypertrophic pulmonary osteoarthropathy

41
Q

What cells do adenocarcinomas arise from?

A

mucous cells in bronchial epithelium

42
Q

Adenocarcinoma important features

A

can invade mediastinal lymph nodes and pleura
can metastasise to brain and bones
does not usually cavitate
if a non-smoker has lung cancer it will be adenocarcinoma
most likely to cause pleural effusions

43
Q

Small cell carcinoma important features

A

cause paraneoplastic syndromes (eg. Cushing’s, Addison’s)
spreads early - almost always inoperable
do respond to chemotherapy but have a poor prognosis

44
Q

What cells do small cell carcinomas arise from?

A

endocrine cells (Kulchitsky cells)

45
Q

Contraindications to surgery for lung cancer

A

malignant pleural effusion
SVCO
Horner’s syndrome
Vocal cord paralysis
Phrenic nerve paralysis

46
Q

What is radical chemotherapy?

A

given with the aim of cure
accept the likely side effects, longer course than palliative which is for symptom control

47
Q

What are 3 types of staging?

A

clinical staging (scans)
surgical staging (biopsies)
pathological staging

48
Q

NSCLC good prognostic factors

A

early stage disease at diagnosis
good performance status
no significant weight loss (<4%)
female

49
Q

Common biomarkers in lung cancer

A

EGFR (epidermal growth factor receptor)
K-ras oncogene
EML4-ALK Fusion oncogene
PDL1

50
Q

Squamous cell carcinoma immunohistochemical staining

A

TTF-1 negative
p63 positive
cytokeratin 5/6 positive

51
Q

Adenocarcinoma immunohistochemical staining

A

TTF-1 positive

52
Q

Small cell lung cancer paraneoplastic syndromes

A

SIADH
Ectopic ACTH production (Cushing’s)
Eaton-Lambert myasthenic syndrome
Hypercalcaemia
Peripheral neuropathy
PE/DVT risk

53
Q

Where does SCLC metastasise to?

A

BALLS
Brain
Adrenal
Liver
Lung
Skeleton

54
Q

SCLC biomarkers

A

nearly all immunoreactive for keratin, epithelial membrane antigen and thyroid transcription factor-1 (TTF-1)

most also stain positive for markers of neuroendocrine differentiation (eg. chromogranin A)